Natixis Investment Managers International Amgen Inc Transaction History

Natixis Investment Managers International

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $568,238 - $632,350	2,463 Added 46.78%	7,728 $1.88 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.15 Million - $1.28 Million	5,265 New	5,265 $1.27 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $3.45 Million - $4.03 Million	-19,330 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.86 Million - $2.1 Million	10,065 Added 108.63%	19,330 $4.01 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $13,616 - $15,293	82 Added 0.89%	9,265 $1.71 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.08 Million - $1.26 Million	6,373 Added 226.8%	9,183 $1.57 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $1.06 Million - $1.19 Million	-6,296 Reduced 69.14%	2,810 $489,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $367,201 - $419,245	-2,195 Reduced 19.42%	9,106 $1.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	11,301	11,301 $1.95 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.